Advertisement
Journal Home
Search for

Volume 287, Issue 1, Pages 60-63 (15 December 2009)


View previous. 11 of 63 View next.

Role of the Oral Glucose Tolerance Test (OGTT) in the idiopathic restless legs syndrome

Domenico BoscoaCorresponding Author Informationemail address, Massimiliano Plastinoa, Antonietta Favag, Maria Ettorea, Francesca Boscob, Caterina Ermioc, Federico Tallarigoe, Domenico Pirritanof, Domenico Consolid

Received 10 April 2009; received in revised form 4 September 2009; accepted 8 September 2009. published online 28 September 2009.

Abstract 

Background

Restless legs syndrome (RLS) is a sensorimotor disorder characterised by a distressing urge to move the legs. Several clinical conditions have been associated with RLS, such as iron deficiency, uraemia, pregnancy, polyneuropathy and Diabetes Mellitus (DM). However the causes remain unknown in about 70–80% of cases.

Objective

To evaluate the role of glucose metabolism abnormalities in idiopathic RLS.

Methods

We enrolled 132 consecutive patients with idiopathic RLS associated with normal fasting glycaemia and 128 control subjects. We evaluated glucose and insulin levels after a 2-h oral glucose tolerance test (2h-OGTT) in patients and control subjects. In addition we determined Insulin Resistance (IR) by Homa-Index.

Results

After 2h-OGTT, the prevalence of glucose metabolism abnormalities was significantly higher in patients with RLS than in controls (P=.002). Impaired Glucose Tolerance (IGT) was found in 54 (41%) patients and in 23 (18%) controls, while a new-diagnosed DM (NDDM) was found in 25 (19%) patients and in 8 (6%) controls. The IR showed no significant differences between patients and controls.

Conclusions

Our study suggests that IGT (prediabetes) is frequently associated with idiopathic RLS. We propose to perform a 2h-OGTT in idiopathic RLS patients with normal fasting glycaemia.

a Department of Neuroscience, “S. Giovanni di Dio” Hospital, 88900, Crotone, Italy

b Pharmacology, Course of Clinical Pharmacy, loc. Roccelletta, University “Magna Graecia”, 88100 Catanzaro, Italy

c Department of Neuroscience, “S. Giovanni Paolo II Hospital, 88046, Lamezia Terme, Italy

d Department of Neuroscience, “G. Jazzolino” Hospital, 89900, Vibo Valentia, Italy

e Serv. of Anatomo-Pathology, “S. Giovanni di Dio Hospital, 88900, Crotone, Italy

f Neurology, Department of Medical Science, Campus Universitario, loc. Germaneto, University “Magna Graecia”, 88100, Catanzaro, Italy

g Endocrinology, Department of Clinical and Experimental Medicine, Campus Universitario, loc. Germaneto, University “Magna Graecia”, 88100, Catanzaro, Italy

Corresponding Author InformationCorresponding author. Department of Neuroscience, “S. Giovanni di Dio” Hospital, Via Largo Bologna, 88900, Crotone, Italy. Tel.: +39 0962 92 42 41; fax: +39 0962 92 45 61.

PII: S0022-510X(09)00850-8

doi:10.1016/j.jns.2009.09.008


View previous. 11 of 63 View next.

Advertisement